Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.80 |
| ▸ | MAPT | P10636 | 8/20 | 0.80 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.80 |
| ▸ | RXRA | P19793 | 5/20 | 0.80 |
| ▸ | RARA | P10276 | 4/20 | 0.80 |
| ▸ | RARB | P10826 | 4/20 | 0.80 |
| ▸ | RARG | P13631 | 4/20 | 0.80 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.80 |
| ▸ | APP | P05067 | 4/20 | 0.80 |
| ▸ | SNCA | P37840 | 4/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.80 |
| ▸ | BLM | P54132 | 3/20 | 0.80 |
| ▸ | LMNA | P02545 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 3/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | RXRB | P28702 | 2/20 | 0.80 |
| ▸ | RXRG | P48443 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4862741 | 0.98 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| Alcohol SCHEMBL1362664 | 0.96 | ALDH1A1 (0.73) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL7890783 | 0.95 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL7523937 | 0.95 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL11125160 | 0.95 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL5225545 | 0.95 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL21587 | 0.95 | ALDH1A1 (0.77) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL27679011 | 0.94 | ALDH1A1 (0.79) | ALDH1A1MAPTCYP3A4RXRARARA | |
| Glycolic Acid SCHEMBL6353225 | 0.94 | ALDH1A1 (0.74) | ALDH1A1MAPTCYP3A4RXRARARA | |
| SCHEMBL15609125 | 0.94 | ALDH1A1 (0.78) | ALDH1A1MAPTCYP3A4RXRARARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744644-A1 | COSMETIC PREPARATION FOR REJUVENATING THE SKIN | Prima-Derm, S.L. (ES) | 2026-05-20 | — | — | EP | claimed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | claimed |
| US-20250381129-A1 | ANTI-AGING SKIN CARE COMPOSITION | L'OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | claimed |
| EP-4622621-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | Symrise AG (DE) | 2025-10-01 | — | — | EP | claimed |
| US-20250143988-A1 | COMPOSTITION WITH STABILIZED TASTE AND ODOR | SYMRISE AG (DE) | 2025-05-08 | — | — | US | claimed |
| EP-3230302-B1 | CARRIER MOLECULE COMPOSITIONS AND RELATED METHODS | JYSK SKIN SOLUTIONS PTE LTD (SG) | 2025-04-30 | — | — | EP | claimed |
| WO-2024136610-A1 | COMPOSITION COMPRISING PH-SENSITIVE LIPID NANOPARTICLES CONTAINING CATIONIC MATERIAL | 동아제약 주식회사 | 2024-06-27 | — | — | WO | claimed |
| US-12011498-B2 | Compositions and methods for preventing and reversing aspects of aging | CENTERS FOR AGE CONTROL INC (US) | 2024-06-18 | — | — | US | claimed |
| WO-2024110023-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | claimed |
| EP-3230302-A1 | CARRIER MOLECULE COMPOSITIONS AND RELATED METHODS | Jjsk R & D Pte Ltd (SG) | 2017-10-18 | — | — | EP | claimed |
| WO-2016092365-A1 | CARRIER MOLECULE COMPOSITIONS AND RELATED METHODS | JJSK R&D Pte Ltd (SG) | 2016-06-16 | — | — | WO | claimed |
| US-20160166703-A1 | Carrier Molecule Compositions and Related Methods | JYSK SKIN SOLUTIONS PTE. LTD. (SG) | 2016-06-16 | — | — | US | claimed |
| EP-2649986-A2 | Cosmetic composition for rejuvenating the skin and corresponding method and uses | Umbert Millet, Ignacio (ES) | 2013-10-16 | — | — | EP | claimed |
| US-7173062-B2 | Prevent skin wrinkling; using retinyl retinoate | ENPRANI CO., LTD. (KR) | 2007-02-06 | — | — | US | claimed |
| EP-1351919-A4 | RETINOL DERIVATIVES AND PROCESS FOR PREPARING SAME | ENPRANI CO LTD (KR) | 2006-05-17 | — | — | EP | claimed |
| US-20040062781-A1 | Retinol derivatives and process for preparing same | ENPRANI CO., LTD. (KR) | 2004-04-01 | — | — | US | claimed |
| EP-1351919-A1 | RETINOL DERIVATIVES AND PROCESS FOR PREPARING SAME | Enprani Co., Ltd. (KR) | 2003-10-15 | — | — | EP | claimed |
| WO-2002057212-A1 | RETINOL DERIVATIVES AND PROCESS FOR PREPARING SAME | ENPRANI CO., LTD. (KR) | 2002-07-25 | — | — | WO | claimed |
| US-6180670-B1 | RETINYL ESTER | AVON PRODUCTS, INC. | 2001-01-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250143988-A1 | COMPOSTITION WITH STABILIZED TASTE AND ODOR | TAS2R16, TAS2R8, FFAR2 | ALDH1A1 1076/4885MAPT 3109/4885CYP3A4 3246/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | ALDH1A1 156/4885MAPT 781/4885CYP3A4 2860/4885 |
| US-20040062781-A1 | Retinol derivatives and process for preparing same | LRAT, RBP4, RBP1 | ALDH1A1 181/4885MAPT 3561/4885CYP3A4 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.